The exception was superoxide dismutase 2; in this case there was a clear trend, but the results were not statistically significant (Fig. 2 ; Additional file 3 : Figure S1, Additional file 4 : Figure S2 and Additional file 5 : Figure S3).
← all excerpts
An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
1
—
—